Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
1.640
-0.020 (-1.20%)
At close: Sep 12, 2025, 4:00 PM EDT
1.670
+0.030 (1.83%)
After-hours: Sep 12, 2025, 6:58 PM EDT

Immutep Revenue

In the fiscal year ending June 30, 2025, Immutep had annual revenue of 5.04M AUD with 31.28% growth. Immutep had revenue of 1.90M in the half year ending June 30, 2025, with 4.17% growth.

Revenue (ttm)
5.04M AUD
Revenue Growth
+31.28%
P/S Ratio
67.74
Revenue / Employee
162,702 AUD
Employees
31
Market Cap
224.01M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20255.04M1.20M31.28%
Jun 30, 20243.84M336.16K9.59%
Jun 30, 20233.51M-1.21M-25.64%
Jun 30, 20224.71M851.56K22.04%
Jun 30, 20213.86M-9.88M-71.88%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings